Altered expression of L-arginine metabolism pathway genes in chronic wounds in recessive dystrophic epidermolysis bullosa

Clinical and Experimental Dermatology

Volumn 29, Issue 6, 2004, Pages 664-668

  Wessagowit, V ^a   Mallipeddi, R ^a   McGrath, J A ^a   South, A F ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; ARGININE; NITRIC OXIDE;

AMINO ACID METABOLISM; ARTICLE; BLISTER; CANCER RISK; CASE REPORT; CONTROLLED STUDY; CYTOLOGY; EPIDERMOLYSIS BULLOSA DYSTROPHICA; FEMALE; GENODERMATOSIS; HUMAN; HUMAN TISSUE; HYBRIDIZATION; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; WOUND; WOUND HEALING;

ADULT; ARGINASE; ARGININE; CHRONIC DISEASE; EPIDERMOLYSIS BULLOSA DYSTROPHICA; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SKIN; WOUND HEALING;

EID: 9644260341     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2004.01627.x     Document Type: Article

References (21)

1. Fine JD, Eady RA, Bauer EA et al. Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol 2000; 42: 1051-66.
2. Mallipeddi R. Epidermolysis bullosa and cancer. Clin Exp Dermatol 2002; 27: 616-23.
3. Mallipeddi R, Wessagowit V, South AP et al. Reduced expression of insulin like growth factor binding protein-3 (IGFBP-3) in squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2004; 122: 1302-9.
4. Wu G, Morris SM Jr. Arginine metabolism: nitric oxide and beyond. Biochem J 1998; 336: 1-17.
5. Stallmeyer B, Kampfer H, Kolb N et al. The function of nitric oxide in wound repair: inhibition of inducible nitric oxide-synthase severely impairs wound reepithelialization. J Invest Dermatol 1999; 113: 1090-8.
6. Abd-El-Aleem SA, Ferguson MW, Appleton I et al. Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcers. J Pathol 2000; 191: 434-12.
7. Jude EB, Boulton AJ, Ferguson MW, Appleton I. The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor beta 1. Diabetologia 1999; 42: 748-57.
8. Kampfer H, Pfeilschifter J, Frank S. Expression and activity of arginase isoenzymes during normal and diabetes-impaired skin repair. J Invest Dermatol 2003; 121: 1544-51.
9. Bruch-Gerharz D, Schnorr O, Suschek C et al. Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation. Am J Pathol 2003; 162: 203-11.
10. Childs AC, Mehta DJ, Gerner EW. Polyamine-dependent gene expression. Cell Mol Life Sci 2003; 60: 1394-406.
11. Hayashi S, Murakami Y, Matsufuji S. Ornithine decarboxylase antizyme: a novel type of regulatory protein. Trends Biochem Sci 1996; 21: 27-30.
12. Gimelli G, Giglio S, Zuffardi O et al. Gene dosage of the spermidine/spermine N(1)-acetyltransferase (SSAT) gene with putrescine accumulation in a patient with a Xp21.1p22.12 duplication and keratosis follicularis spinulosa decalvans (KFSD). Hum Genet 2002; 111: 235-41.
13. Albina JE, Mills CD, Barbul A et al. Arginine metabolism in wounds. Am J Physiol 1988; 254: E459-E467.
14. Castillo L, Beaumier L, Ajami AM, Young VR. Whole body nitric oxide synthesis in healthy men determined from [15N]arginine-to-[15N]citrulline labeling. Proc Natl Acad Sci USA 1996; 93: 11460-5.
15. Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev 2000; 80: 1107-213.
16. Jenkinson CP, Grody WW, Cederbaum SD. Comparative properties of arginases. Comp Biochem Physiol B Biochem Mol Biol 1996; 114: 107-32.
17. Shi O, Morris SM Jr, Zoghbi H et al. Generation of a mouse model for arginase II deficiency by targeted disruption of the arginase II gene. Mol Cell Biol 2001; 21: 811-3.
18. Iyer RK, Yoo PK, Kern RM et al. Mouse model for human arginase deficiency. Mol Cell Biol 2002; 22: 4491-8.
19. Witte MB, Thornton FJ, Tantry U, Barbul A. L-Arginine supplementation enhances diabetic wound healing: involvement of the nitric oxide synthase and arginase pathways. Metabolism 2002; 51: 1269-73.
20. Shi HP, Fishel RS, Efron DT et al. Effect of supplemental ornithine on wound healing. J Surg Res 2002; 106: 299-302.
21. Lirk P, Hoffmann G, Rieder J. Inducible nitric oxide synthase - time for reappraisal. Curr Drug Targets Inflamm Allergy 2002; 1: 89-108.